Inhibition of pluripotent stem cell-derived teratoma formation by small molecules

The future of safe cell-based therapy rests on overcoming teratoma/tumor formation, in particular when using human pluripotent stem cells (hPSCs), such as human embryonic stem cells (hESCs) and human induced pluripotent stem cells (hiPSCs). Because the presence of a few remaining undifferentiated hP...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Lee, Mi-Ok, Moon, Sung Hwan, Jeong, Ho-Chang, Yi, Ji-Yeon, Lee, Tae-Hee, Shim, Sung Han, Rhee, Yong-Hee, Lee, Sang-Hun, Oh, Seok-Jeong, Lee, Moo-Yeol, Han, Min-Joon, Cho, Yee Sook, Chung, Hyung-Min, Kim, Kwang-Soo, Cha, Hyuk-Jin
Format: Artigo
Idioma:Inglês
Publicat: National Academy of Sciences 2013
Matèries:
PNAS Plus
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3761568/
https://ncbi.nlm.nih.gov/pubmed/23918355
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.1303669110
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars